Please assess the completion status of the following clinical trial:

Trial Title: Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Key Eligibility Criteria:~* Must have had HIV-associated neuropathy for at least 2 months, with moderate to severe pain in both feet.~* Must not have significant pain in feet due to other causes (for example, arthritis).~* Must have intact skin at the treatment area.~* Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (12 weeks).~* Must not use topical pain medications for HIV-associated neuropathy.~* Must be able to comply with study requirements such as completing daily pain diary and attending study visits.~* Must be at least 18 years old, not pregnant, and be able to take care of self independently, with only occasional assistance if needed.~* No significant medical problems of the heart, kidneys, liver or lungs, or cancer.~* No history or current problem with substance abuse.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).